This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2.CL Gyles . Shiga toxin-producing Escherichia coli: an overview. Journal of Animal Science 2007; 85: E45–62.
3.E Scallan , Foodborne illness acquired in the United States – major pathogens. Emerging Infectious Diseases 2011; 17: 7–15.
8.RC Williams , Illness outbreak associated with Escherichia coli O157:H7 in Genoa salami. Canadian Medical Association Journal 2000; 162: 1409–1413.
11.LA Trotz-Williams , Pork implicated in a Shiga toxin-producing Escherichia coli O157:H7 outbreak in Ontario, Canada. Canadian Journal of Public Health 2012; 103: e322–326.
13.O Pinaka , Shiga toxin-producing Escherichia coli in Central Greece: prevalence and virulence genes of O157:H7 and non-O157 in animal faeces, vegetables, and humans. European Journal of Clinical Microbiology and Infectious Diseases 2013; 32: 1401–1408.
16.I Feder , Isolation of Escherichia coli O157:H7 from intact colon faecal samples of swine. Emerging Infectious Diseases 2003; 9: 380–383.
17.PM Fratamico , Prevalence and characterization of Shiga toxin-producing Escherichia coli in swine faeces recovered in the National Animal Health Monitoring System's Swine 2000 study. Applied and Environmental Microbiology 2004; 70: 7173–7178.
Influence of primer sequences and DNA extraction method on detection of non-O157 Shiga toxin-producing Escherichia coli in ground beef by real-time PCR targeting the eae, stx, and serogroup-specific genes. Journal of Food Protection
2012; 75: 1939–1950.
20.JJ Hirvonen , A Siitonen , S-S Kaukoranta . Usability and performance of CHROMagar STEC medium in detection of Shiga toxin-producing Escherichia coli strains. Journal of Clinical Microbiology 2012; 50: 3586–3590.
21.JL Wylie , Evaluation of a new chromogenic agar medium for detection of Shiga toxin-producing Escherichia coli (STEC) and relative prevalences of O157 and non-O157 STEC in Manitoba, Canada. Journal of Clinical Microbiology 2013; 51: 466–471.
22.M Gouali , Evaluation of CHROMagar STEC and STEC O104 chromogenic agar media for detection of Shiga toxin-producing Escherichia coli in stool sepcimens. Journal of Clinical Microbiology 2013; 51: 894–900.
24.M Bugarel , Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiology 2011; 11: 142.
25.SL Booher , NA Cornick , HW Moon . Persistence of Escherichia coli O157:H7 in experimentally infected swine. Veterinary Microbiology 2002; 89: 69–81.
. Transmission and infectious dose of Escherichia coli O157:H7 in swine. Applied and Environmental Microbiology
2004; 70: 5331–5335.
27.L Beutin , Identification of human-pathogenic strains of Shiga toxin-producing Escherichia coli from food by a combination of serotyping and molecular typing of Shiga toxin genes. Applied and Environmental Microbiology 2007; 73: 4769–4775.
28.L Galli , Virulence profile comparison between LEE-negative Shiga toxin-producing Escherichia coli (STEC) strains isolated from cattle and humans. Veterinary Microbiology 2010; 143: 307–313.
29.U Kappeli , Human infections with non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000–2009. Emerging Infectious Diseases 2011; 17: 180–185.
30.A Thomas , Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome. European Journal of Clinical Microbiology and Infectious Diseases 1994; 13: 1074–1076.
31.D Pierard , Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin. Lancet 1991; 338: 762.
32.M Muniesa , Characterization of a Shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin. Infection and Immunity 2000; 68: 4850–5.
33.AW Friedrich , Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. Journal of Infectious Diseases 2002; 185: 74–84.
34.L Beutin , Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. Journal of Clinical Microbiology 2004; 42: 1099–1108.
35.PM Fratamico , Characterization of Shiga toxin-producing Escherichia coli strains isolated from swine faeces. Foodborne Pathogen and Disease 2008; 5: 827–838.
36.M Lenahan , Molecular characterization of Irish E. coli O157:H7 isolates of human, bovine, ovine and porcine origin. Journal of Applied Microbiology 2009; 107: 1340–1349.
. Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cellular Microbiology
2008; 10: 549–556.
Escherichia coli O157:H7 does not require intimin to persist in pigs. Infection and Immunity
2005; 73: 1865–1867.
39.M Bielaszewska , Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. The Lancet Infectious Diseases 2011; 11: 671–676.
40.AW Paton , Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infection and Immunity 2001; 69: 6999–7009.